CNBC Investing Club

Cramer's Investing Club: We're adding to our position in this drugmaker on weakness

Eli Lilly Pharmaceutical company logo
SOPA Images | LightRocket | Getty Images

We are buying 25 shares of Eli Lilly (LLY) at roughly $235.01. Following the trade, the Charitable Trust will own 500 shares of Eli Lilly. This buy will increase LLY's weight in the portfolio from about 2.92% to 3.07%. 

More In CNBC Investing Club Newsletter

CNBC Investing ClubEli Lilly rallies on FDA approval of a diabetes drug that may also help with obesity
CNBC Investing ClubWhat Cramer is watching Monday — McDonald's is leaving Russia, China lockdowns slam tech
CNBC Investing ClubWe're expanding our stable of oil and natural gas stocks as energy prices remain elevated